STOCKSCOPE

Wildcat Resources (ASX: WC8): Can Tabba Tabba Turn Lithium Potential Into a Fundable Mine?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:26 Oct 2026
Wildcat Resources (ASX: WC8): Can Tabba Tabba Turn Lithium Potential Into a Fundable Mine?

Wildcat’s definitive feasibility study (DFS) moves its flagship project closer to a development decision, but the scale of the opportunity comes with a substantial funding challenge.

  • A$1.5 billion: projected post-tax net present value (NPV).
  • 28.4%: forecast post-tax internal rate of return (IRR).
  • A$774 million: estimated pre-production capital expenditure.
  • 600,000 tonnes a year: targeted spodumene concentrate production by year three.
  • A$76.1 million: cash held at 30 September 2026, before considering subsequent funding movements.

Can the economics survive a tougher reality?

Tabba Tabba is a 100%-owned lithium project in Western Australia’s Pilbara, around 80km by road from Port Hedland. Its location near established hard-rock lithium operations offers potential logistical advantages, while the project’s resource base provides a foundation for a substantial mining operation.

The DFS outlines a pathway to accelerate production, bringing forward approximately 1 million tonnes of concentrate and A$1 billion in additional post-tax free cash flow by 2035.

That is meaningful, but the distinction between projected economics and cash actually generated matters. The NPV depends on assumptions including lithium prices, operating costs, production performance and capital requirements. A strong headline return does not eliminate commodity-price risk.

Wildcat’s shares closed at 21.5 cents on 23 October, down approximately 23% from 28 cents on 2 October. The decline preceded the DFS announcement, so it should not be attributed to the study. The new economics provide a fresh benchmark against which the market can reassess the project.

What stands out to us

Our view is that Wildcat’s story is changing from resource discovery towards development execution. That can broaden the company’s potential appeal, but it also raises the stakes. The key question is no longer simply whether Tabba Tabba contains substantial lithium mineralisation. It is whether Wildcat can finance, build and operate a mine capable of delivering the forecast returns through the lithium cycle.

What is Wildcat doing now?

Wildcat has raised A$60 million through an institutional placement, strengthening its balance sheet and funding early development work. It is also advancing engineering, approvals and construction-readiness activities at Tabba Tabba, while progressing its Bolt Cutter Central discovery, where a maiden mineral resource estimate is targeted for the December quarter of 2026.

These initiatives create additional opportunities, although the larger development will require substantially more capital than the company currently holds. Project financing, offtake agreements and potential strategic partnerships will therefore be critical.

Insight: Is the A$1.5 billion NPV enough?

We see the DFS as an important de-risking milestone, not proof that the projected value will be realised. The estimated A$774 million capital requirement is more than ten times Wildcat’s September cash balance, highlighting the gap between project economics and funding capacity. Our assessment will depend increasingly on financing terms, dilution risk and the resilience of projected cash flows under weaker lithium prices.

The next milestone could change the story

The focus now shifts to project financing, approvals and commercial agreements. Wildcat has established a potentially substantial development opportunity, but the next test is whether it can convert the DFS into a financeable construction plan without materially weakening existing shareholders’ position.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...